MedTrace Logo

ABTEST© Card Clinical Perfomance Study

NCT05140395 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2021-12-01

No results posted yet for this study

Summary

The study confirms the performance equivalence of the in vitro Diagnostic reagent ABTEST card used with the new reformulated WS solution

Conditions

  • Transfusion Reaction

Interventions

DIAGNOSTIC_TEST

ABTEST card

Pre transfusional control with the referent ABTEST card and the in study ABDTEST Card

Sponsors & Collaborators

  • Diagast

    lead INDUSTRY

Principal Investigators

  • Pascal Huchette, phD · CH Arras

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-06
Primary Completion
2021-10-28
Completion
2021-11-04

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05140395 on ClinicalTrials.gov